Is SNBIF or NOBL a better dividend investment in 2026?

SNBIF currently yields 12.16% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: SNBIF offers higher current income.

What is the dividend yield difference between SNBIF and NOBL?

SNBIF has a forward dividend yield of 12.16% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 8.16 percentage points.

Home › Compare › SNBIF vs NOBL

SNBIF vs NOBL: Dividend Comparison 2026

SNBIF yields 12.16% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SNBIF wins by $16.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SNBIF

● Live price

12.16%

Share price

$16.45

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.6K

Annual income

$2,595.30

Full SNBIF calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — SNBIF vs NOBL

📍 SNBIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SNBIF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SNBIF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SNBIF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNBIF

Annual income on $10K today (after 15% tax)

$1,033.43/yr

After 10yr DRIP, annual income (after tax)

$2,206.01/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, SNBIF beats the other by $1,441.69/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNBIF + NOBL for your $10,000?

SNBIF: 50%NOBL: 50%

100% NOBL50/50100% SNBIF

Portfolio after 10yr

$36.3K

Annual income

$1,747.25/yr

Blended yield

4.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NOBL right now

SNBIF

Analyst Ratings

Sell

Consensus: Sell

Altman Z

60.9

Piotroski

2/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNBIF buys

NOBL buys

No recent congressional trades found for SNBIF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSNBIFNOBL

Forward yield	12.16% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$44.6K ✓	$28.0K
Annual income after 10y	$2,595.30 ✓	$899.19
Total dividends collected	$18.9K ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SNBIF vs NOBL ($10,000, DRIP)

Year	SNBIF Portfolio	SNBIF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$11,916	$1,215.81	$11,120	$420.00	+$796.00 → SNBIF
2	$14,104	$1,353.95	$12,357	$458.31	+$1.7K → SNBIF
3	$16,589	$1,497.73	$13,721	$499.76	+$2.9K → SNBIF
4	$19,396	$1,646.38	$15,227	$544.58	+$4.2K → SNBIF
5	$22,553	$1,799.08	$16,885	$593.02	+$5.7K → SNBIF
6	$26,087	$1,955.04	$18,713	$645.34	+$7.4K → SNBIF
7	$30,027	$2,113.43	$20,724	$701.81	+$9.3K → SNBIF
8	$34,402	$2,273.44	$22,938	$762.73	+$11.5K → SNBIF
9	$39,244	$2,434.31	$25,372	$828.41	+$13.9K → SNBIF
10	$44,587	$2,595.30	$28,047	$899.19	+$16.5K → SNBIF

SNBIF vs NOBL: Complete Analysis 2026

SNBIF — Stock

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.

Full SNBIF Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this SNBIF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNBIF vs SCHD SNBIF vs JEPI SNBIF vs O SNBIF vs KO SNBIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.